Vice President, Medical Affairs, Hematology-Oncology

About the Company

Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases.

Responsibilities

• Lead and scale the Medical Affairs function to support hematology-oncology programs into late-stage clinical development and commercial readiness
• Own the overall Medical Affairs strategy for the hematology-oncology portfolio
• Develop the scientific platform and differentiated medical narrative for Nurix programs
• Partner with Clinical Development to shape late-stage medical strategy and data generation priorities
• Expand and lead a high-performing MSL organization
• Lead external engagement with key experts, investigators, and scientific communities
• Direct publication and scientific communication strategy for clinical data and congress presentations
• Lead integrated evidence generation strategies including RWE and HEOR
• Partner with Commercial and Market Access to ensure launch readiness
• Ensure all activities comply with legal, regulatory, and company standards

Requirements

• MD, PhD, DO, or PharmD
• Oncology or hematology experience
• 15+ years of biopharmaceutical Medical Affairs experience with significant leadership responsibility
• Experience with launch and post-approval accountability
• Expertise in evidence generation (Phase 3b/4, RWE, HEOR)
• Experience in scientific communications and MSL leadership
• Strong understanding of US and global regulatory, compliance, and payer environments

Preferred Qualifications

• Experience in highly innovative therapeutic platforms or first-in-class mechanisms
• Proven ability to build and scale Medical Affairs organizations in emerging biotechnology settings